![](/img/cover-not-exists.png)
1109OA phase II study of monalizumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN): Results of the I1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)
Galot, R, Le Tourneau, C, Saada-Bouzid, E, Daste, A, Even, C, Debruyne, P R, Henry, S, Zanetta, S, Rutten, A, Licitra, L F, Canon, J-L, Kaminsky-Forrett, M-C, Specenier, P, Rottey, S, Dirix, L, RaveloVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz252.001
Date:
October, 2019
File:
PDF, 104 KB
2019